W. Meyer

发表

Reduced α1‐ and β2‐adrenoceptor‐mediated positive inotropic effects in human end‐stage heart failure

M. Steinfath, W. Schmitz, A. Haverich, 1992 .

Phosphodiesterase inhibition and positive inotropic effects.

W. Schmitz, H. E. von der Leyen, H. Scholz, 1989, Journal of cardiovascular pharmacology.

Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations

W. Schmitz, A. Haverich, H. Leyen, 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations.

W. Schmitz, P. Kalmar, H. Scholz, 1989, Journal of cardiovascular pharmacology.

Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts

H. Leyen, H. Scholz, T. Bethke, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea‐pig hearts

W. Schmitz, H. Scholz, B. Stein, 1992, British journal of pharmacology.

Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium.

W. Schmitz, A. Mügge, H. Scholz, 1984, European journal of pharmacology.

Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart

H. Leyen, H. Scholz, W. Meyer, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

Phosphodiesterase-inhibiting properties of newer inotropic agents.

H. Scholz, W. Meyer, 1986, Circulation.

Reduced a1- and fl2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure

M. Steinfath, W. Schmitz, H. Scholz, 2006 .

Positive inotropic effect of bay K 8644: cAMP-independence and lack of inhibitory effect of adenosine

M. Böhm, W. Schmitz, H. Scholz, 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

Functional evidence for the existence of adenosine receptors in the human heart.

M. Böhm, W. Schmitz, A. Mügge, 1985, European journal of pharmacology.

Influence of endothelium and nitrovasodilators on free thiols and disulfides in porcine coronary smooth muscle.

G. Kojda, E. Noack, W. Meyer, 1993, European journal of pharmacology.

The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits

G. Kojda, B. Fink, V. Thämer, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Nitrovasodilator‐induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium

J. K. Beck, G. Kojda, E. Noack, 1994, British journal of pharmacology.

Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.

H. E. von der Leyen, T. Eschenhagen, J. Neumann, 1992, Arzneimittel-Forschung.

MECHANISMS OF ACTION

H. Scholz, W. Meyer, 2005 .

Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP.

W. Schmitz, H. Scholz, W. Meyer, 1985, The Journal of pharmacology and experimental therapeutics.

Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase.

G. Kojda, D. Harrison, U. Rüther, 2005, Cardiovascular research.

Nitric Oxide and Cardiovascular Pharmacology nhibition of Vascular Oxidative tress in Hypercholesterolemia y Eccentric Isosorbide Mononitrate

G. Kojda, E. Müller, W. Meyer, 2016 .

Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate.

G. Kojda, W. Meyer, I. König, 2004, Journal of the American College of Cardiology.

Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.

B. Haubitz, M. Böhm, W. Schmitz, 1984, The Journal of pharmacology and experimental therapeutics.

Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations

M. Böhm, W. Schmitz, H. Scholz, 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

Adenosine and adenosine analogs inhibit phosphodiesterase activity in the heart

W. Schmitz, H. Scholz, M. Nose, 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

Endogenous Vascular Hydrogen Peroxide Regulates Arteriolar Tension In Vivo

G. Kojda, R. Jacob, N. Lauer, 2005, Circulation.

Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance.

G. Kojda, J. Müllenheim, W. Meyer, 2003, Journal of the American College of Cardiology.

Effect of Hypercholesterolemia on Expression and Function of Vascular Soluble Guanylyl Cyclase

G. Kojda, B. Mayer, A. Schrammel, 2002, Circulation.

Effects of Isomazole on Force of Contraction and Phosphodiesterase Isoenzymes I‐IV in Nonfailing and Failing Human Hearts

W. Schmitz, A. Haverich, H. E. von der Leyen, 1991, Journal of cardiovascular pharmacology.

Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.

M. Steinfath, W. Schmitz, H. E. von der Leyen, 1992, British journal of pharmacology.

The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis

G. Kojda, W. Meyer, A. Hacker, 2001, British journal of pharmacology.

High Selectivity for Inhibition of Phosphodiesterase III and Positive Inotropic Effects of MCI‐154 in Guinea Pig Myocardium

W. Schmitz, H. Scholz, B. Armah, 1993, Journal of cardiovascular pharmacology.

Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.

C. Berger, H. Scholz, J. Starbatty, 1985, Arzneimittel-Forschung.

Inotropic response in CHF: myocarditis vs dilated cardiomyopathy.

W. Schmitz, J. Scholz, P. Kalmar, 1988, American Heart Journal.